Lecithinized superoxide dismutase in the past and in the present: Any role in the actual pandemia of COVID-19? - 03/09/21
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
The Coronavirus disease 19 (Covid-19) pandemic is devastating the public health: it is urgent to find a viable therapy to reduce the multiorgan damage of the disease. A validated therapeutic protocol is still missing. The most severe forms of the disease are related to an exaggerated inflammatory response. The pivotal role of reactive oxygen species (ROS) in the amplification of inflammation makes the antioxidants a potential therapy, but clinical trials are needed. The lecitinized superoxide dismutase (PC-SOD) could represent a possibility because of bioaviability, safety, and its modulatory effect on the innate immune response in reducing the harmful consequences of oxidative stress. In this review we summarize the evidence on lecitinized superoxide dismutase in animal and human studies, to highlight the rationale for using the PC-SOD to treat COVID-19.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Oxidative stress worsens tissue damage in covid-19 disease. |
• | Lecitinized superoxide dismutase is a bioavailable and safe antioxidant enzyme. |
• | Lecitinized superoxide dismutase could be tested in covid-19 disease. |
Keywords : Lecitinized superoxide dismutase, Superoxide mimetics, Lung infections, Oxidative stress, Antioxidants, COVID-19 disease
Plan
Vol 141
Article 111922- septembre 2021 Retour au numéro
Article précédent
- Silk fibroin nanocomposites as tissue engineering scaffolds – A systematic review
- Augusto Zuluaga-Vélez, Adrián Quintero-Martinez, Lina M. Orozco, Juan C. Sepúlveda-Arias
- Natural bioactive molecules: An alternative approach to the treatment and control of glioblastoma multiforme
- Priti Tagde, Pooja Tagde, Sandeep Tagde, Tanima Bhattacharya, Vishal Garg, Rokeya Akter, Md. Habibur Rahman, Agnieszka Najda, Ghadeer M. Albadrani, Amany A. Sayed, Muhammad Furqan Akhtar, Ammara Saleem, Ahmed E. Altyar, Deepak Kaushik, Mohamed M. Abdel-Daim
Bienvenue sur EM-consulte, la référence des professionnels de santé.